Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.

Matteo PiccicaMichele SpinicciAnnarita BottaVincenzo BiancoFilippo LagiLucia GrazianiAlessandro FaragonaRoberto ParrellaTommaso GianiAndrea BartoliniGianluca MorroniMariano BernardoGian Maria RossoliniMarcello TavioAndrea GiacomettiAlessandro Bartoloni

Published in: The Journal of antimicrobial chemotherapy (2023)

Real-life data confirm that cefiderocol is a promising option against carbapenem-resistant Gram-negative infections, even as monotherapy.

Keyphrases

gram negative
multidrug resistant
combination therapy
clinical trial
electronic health record
study protocol
open label
big data
cross sectional
double blind
replacement therapy